Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00384358
What this trial is testing

Feasibility And Safety Study Of rhBMP-2/CPM For Hip Fractures

Who this might be right for
Fractures
Wyeth is now a wholly owned subsidiary of Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT01524848
What this trial is testing

Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib

Who this might be right for
Gastrointestinal Stromal Tumors
Scandinavian Sarcoma Group 72
Testing effectiveness (Phase 2)Looking for participantsNCT07362355
What this trial is testing

The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia

Who this might be right for
Primary Gout and Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 340
Testing effectiveness (Phase 2)WithdrawnNCT02432378
What this trial is testing

Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Who this might be right for
Cancer of OvaryCancer of the OvaryNeoplasms, Ovarian+3 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Looking for participantsNCT07423078
What this trial is testing

Window of Opportunity in Preserving Laryngeal Function Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Matthew Spector 87
Not applicableEnrolling By InvitationNCT06729736
What this trial is testing

Implementation of the ERAS in Colorectal Cancer Patients: a Single Arm Study

Who this might be right for
Colorectal Cancer
Seoul National University Hospital 500
Early research (Phase 1)Looking for participantsNCT06326411
What this trial is testing

Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Who this might be right for
OncologyMEK MutationRAF Gene Mutation+6 more
Nested Therapeutics, Inc 230
Testing effectiveness (Phase 2)UnknownNCT03141671
What this trial is testing

Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509)

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 345
Testing effectiveness (Phase 2)Ended earlyNCT00006371
What this trial is testing

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Who this might be right for
Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Study completedNCT01958944
What this trial is testing

Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Beyond Air Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07481734
What this trial is testing

Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)

Who this might be right for
Metabolic Associated Steatotic Liver DiseaseNonalcoholic SteatohepatitisHepatic Steatosis
Hudson Biotech 120
Testing effectiveness (Phase 2)Study completedNCT04660799
What this trial is testing

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 50
Not applicableStudy completedNCT02869399
What this trial is testing

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention

Who this might be right for
Cancer of Head and Neck
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 94
Large-scale testing (Phase 3)Study completedNCT00117598
What this trial is testing

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma
Pfizer 169
Testing effectiveness (Phase 2)Ended earlyNCT00281021
What this trial is testing

Second Line Erlotinib (Tarceva) Plus Digoxin in Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
University of Louisville 26
Testing effectiveness (Phase 2)Study completedNCT03179904
What this trial is testing

TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer

Who this might be right for
Advanced Breast CarcinomaHER2-Positive Breast CarcinomaAnatomic Stage III Breast Cancer AJCC v8+2 more
Mayo Clinic 17
Testing effectiveness (Phase 2)Study completedNCT01253447
What this trial is testing

AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Ended earlyNCT03943147
What this trial is testing

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 16
Testing effectiveness (Phase 2)Study completedNCT00110058
What this trial is testing

Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Next Page